![](/img/cover-not-exists.png)
Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patients
Hynes, Scott M., Wickremsinhe, Enaksha, Zhang, Wei, Decker, Rodney, Ott, Jennifer, Chandler, Jason, Mitchell, MalcolmVolume:
36
Language:
english
Journal:
Biopharmaceutics & Drug Disposition
DOI:
10.1002/bdd.1922
Date:
January, 2015
File:
PDF, 346 KB
english, 2015